GENOCEA BIOSCIENCES, INC.
DelistedCIK 1457612fmd_00K9VPVFMS26TJB55Z56EDV0YJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2012 to Mar 31, 2022, 38 periods
Latest annual · FY2021
Millions- Total revenues
- 2
- Operating income
- (52)
- Net income
- (33)
- Free cash flow
- (49)
Latest quarter · Q1 FY2022
Millions- Total revenues
- 0
- Operating income
- (16)
- Net income
- (16)
- Free cash flow
- (16)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
- Revenue, 5 yearsFY2016 to FY2021
- n/m
- Net income, 5 yearsFY2016 to FY2021
- n/m
GENOCEA BIOSCIENCES, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.6 million | $1.4 million | +20.8% | 10-K 2022-03-18 · proof |
| Operating income | -$52.1 million | -$47 million | 10-K 2022-03-18 · proof | |
| Net income | -$33.2 million | -$43.7 million | 10-K 2022-03-18 · proof | |
| Cash from operating activities | -$45.4 million | -$41.7 million | 10-K 2022-03-18 · proof | |
| Free cash flow | -$48.7 million | -$44.2 million | 10-K 2022-03-18 · proof | |
| Total assets | $56 million | $98.5 million | -43.2% | 10-K 2022-03-18 · proof |
| Total liabilities | $28.9 million | $89.5 million | -67.7% | 10-K 2022-03-18 · proof |
| Cash and cash equivalents | $37.1 million | $79.8 million | -53.4% | 10-K 2022-03-18 · proof |
| Total debt | $8.8 million | $13.9 million | -36.6% | 10-K 2022-03-18 · proof |
- What was GENOCEA BIOSCIENCES, INC.'s revenue in fiscal 2021?
- GENOCEA BIOSCIENCES, INC. reported revenue of $1.6 million for fiscal 2021 (the year ended Dec 31, 2021), against $1.4 million the year before (+20.8%). Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What was GENOCEA BIOSCIENCES, INC.'s operating income in fiscal 2021?
- GENOCEA BIOSCIENCES, INC. reported operating income of -$52.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$47 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What was GENOCEA BIOSCIENCES, INC.'s net income in fiscal 2021?
- GENOCEA BIOSCIENCES, INC. reported net income of -$33.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$43.7 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What was GENOCEA BIOSCIENCES, INC.'s cash from operating activities in fiscal 2021?
- GENOCEA BIOSCIENCES, INC. reported cash from operating activities of -$45.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$41.7 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What was GENOCEA BIOSCIENCES, INC.'s free cash flow in fiscal 2021?
- GENOCEA BIOSCIENCES, INC. reported free cash flow of -$48.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$44.2 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What are GENOCEA BIOSCIENCES, INC.'s total assets?
- As of Dec 31, 2021, GENOCEA BIOSCIENCES, INC. reported total assets of $56 million, against $98.5 million a year earlier (-43.2%). Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What are GENOCEA BIOSCIENCES, INC.'s total liabilities?
- As of Dec 31, 2021, GENOCEA BIOSCIENCES, INC. reported total liabilities of $28.9 million, against $89.5 million a year earlier (-67.7%). Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What are GENOCEA BIOSCIENCES, INC.'s cash and cash equivalents?
- As of Dec 31, 2021, GENOCEA BIOSCIENCES, INC. reported cash and cash equivalents of $37.1 million, against $79.8 million a year earlier (-53.4%). Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
- What is GENOCEA BIOSCIENCES, INC.'s total debt?
- As of Dec 31, 2021, GENOCEA BIOSCIENCES, INC. reported total debt of $8.8 million, against $13.9 million a year earlier (-36.6%). Source: the 10-K filed with the SEC on Mar 18, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1457612&period_type=annual&limit=5"Information only, not investment advice.